Skip to content

AARD AARD Total Equity

Total Equity at other companies

AbbVie logo
AbbVieABBV
-$6.66B-569%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$218.73M+875%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$122.91M+549%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$34.05M+44.1%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$501.92M-40.7%
Arvinas logo
ArvinasARVN
$386.8M-41.4%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's total equity?
AARD (AARD) reported total equity of $86.99M in Q1 2026.
How has AARD's total equity changed year-over-year?
AARD's total equity decreased by 42.3% year-over-year, from $150.69M to $86.99M.
What is the long-term trend for AARD's total equity?
Over 2 years (2023 to 2025), AARD's total equity has grown at a 75.0% compound annual growth rate (CAGR), from -$34.8M to $106.63M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.